Reason/Issue |
RTI Surgical has been advised that a specific batch of nanOss Bioactive 10cc Bone Void Filler was shipped at the incorrect revision. Although the revision of the product as a whole (implant, accessories, packaging, labelling) was Rev A instead of Rev B, the implant itself remained unchanged and is safe. The changes included removal of an accessory syringe provided for rehydration, and minor changes to the labelling and IFU. No changes between revisions impact patient safety.
To date, there have been zero complaints, as this issue was found internally only. |